top of page

Contract Manufacturing for UK Pharmaceutical Companies

Irish-based oral solid dose manufacturing supporting pharmaceutical and biotech organisations across key

innovation hubs across England, Scotland, Wales, and Northern Ireland - with scalable capacity, technical expertise, and reliable global supply.

Supporting Key UK Pharma Hubs

Eirgen works with organizations across major UK pharmaceutical and biotech clusters, including;

UK.jpg

England

UK’s leading pharmaceutical hub and one of the most important life sciences centres globally. Combines world-renowned universities, a strong clinical research network, and the well-established “Golden Triangle” of Oxford, Cambridge, and London. A magnet for global pharma companies.

Scotland.jpeg

Scotland

Highly respected life sciences sector with a strong focus on research-led innovation. The Central Belt acts as the main hub, with growing collaboration between academia, industry, and government driving continued expansion in pharmaceutical innovation and advanced therapies.

wales.jpg

Wales

Emerging but rapidly developing player in the pharmaceutical and life sciences landscape, offering a strong manufacturing base, growing R&D capability, and increasing investment in innovation clusters across Cardiff, Swansea, and North Wales. 

NI.jpg

Northern Ireland

​Smaller but increasingly competitive life sciences and pharmaceutical hub, known for its agility and cost-effectiveness. Belfast is the focal point, with strengths in advanced manufacturing, diagnostics, and medtech-related services. .

Why UK Pharma Companies Work With Eirgen 

Eirgen Pharma supports UK-based organizations seeking a trusted European manufacturing partner with; 

​

  • Scalable EU-based OSD manufacturing capacity 

  • Support for clinical through to commercial supply ​

  • Expertise in highly potent and non-potent formulations 

  • Flexible outsourcing models for evolving pipeline demands 

  • Reliable supply chain diversification outside EMA and MHRA domestic constraints 

  • Quality systems aligned with global regulatory expectations 

​

We operate as an extension of our partners' manufacturing network - not a transactional supplier.

​

Our Capabilities

Development & Manufacturing

  • High Potency Oral Solid Dose 

  • Softgel Capsule Development & Manufacturing

  • Formulation Development & Optimization 

  • Clinical to Commercial Scale-Up

  • Advanced Packaging for Global Markets

Tech Transfer

 

  • Primary & Secondary Packaging

  • Serialization-Ready Processes (DSCSA-Aligned Where Possible)

  • Commercial Supply for US Distribution​

​

​

​

Stability Checks

 

  • ​Process Optimization & Stability Studies 

  • Post-Approval Changes 

  • Product Lifecycle Management 

  • Continuous Improvement Support 

​

​

​

​

3.png

"Eirgen made outsourcing seamless. Their understanding of the US regulatory environment and ability to scale quickly gave us a clear advantage in a competitive market."

TK, New York

Quality and compliance are central to how we operate.

  • Confidence in cross-border supply chains

  • Smooth integration into MHRA regulatory strategies 

  • Reliable support for global filings and submissions

  • Geographic diversification from UK & European manufacturing hubs

  • Predictable production planning 

  • Export-ready packaging and logistics capability 

  • Long-term supply continuity partnerships

Looking for a reliable European CDMO partner?

Start a conversation with Eirgen Pharma's Business Development Team today.

Thanks for submitting!

bottom of page